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Abstract 
Purpose: To develop and characterize solid dispersions of praziquantel (PZQ) with sodium starch 
glycolate (SSG) for enhanced drug solubility.  
Methods: PZQ solid dispersion (SD) was prepared using co-precipitation method by solvent 
evaporation. The ratios of PZQ to SSG were 2:1, 1:1, 1:2, 1:3 (w/w). PZQ solubility was evaluated in 
purified water, and PZQ dissolution test was carried out in 0.1N HCl. Structural characterization of the 
dispersions was accomplished by x-ray diffraction (XRD) and infrared spectroscopy (FTIR) while the 
external morphology of the SDs, SSG and PZQ were studied by scanning electron microscopy (SEM). 
Mucoadhesion properties of the SD (1:3) and SSG, on mucin disks were examined using texture profile 
analysis. 
Results: The highest solubility was obtained with 1:3 solid dispersion, with PZQ solubility of 97.31 %, 
which is 3.65-fold greater than the solubility of pure PZQ and physical misture (PM, 1:3). XRD results 
indicate a reduction in PZQ crystallinity while infrared spectra showed that the functional groups of PZQ 
and SSG were preserved. SEM showed that the physical structure of PZQ was modified from crystalline 
to amorphous. The amount of PZQ in PM and SD (1:3) that dissolved in 60 min was 70 and 88 %, 
respectively, and these values increased to 76 and 96 %, respectively. The solid dispersion reduced the 
mucoadhesive property of the glycolate. 
Conclusion: Solid dispersion formulation using SSG is a good alternative approach for increasing the 
dissolution rate of PZQ. 
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Poor bioavailability exerts strong limits to the 
performance of a drug by the necessity to 
administer a much higher dose than strictly 
required from a pharmacologic point of view. For 
good oral bioavailability drug must be soluble in 
gastrointestinal fluids, i.e., aqueous soluble and 
possess permeability properties for good 
membrane diffusion in order to reach the 
bloodstream [1]. 
 
Oral bioavailability of poorly soluble and highly 
permeable drugs, whose absorption is controlled 
by dissolution rate, can be increased by 
formulation strategies aimed at increasing both 
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solubility and dissolution rate. Among the several 
strategies available for improving drug 
bioavailability, solid dispersions (SD) have been 
used extensively [2-6]. The SD technique 
produces a significant increase in surface area 
and surface wettability as well as solid state 
modification from crystalline to amorphous form. 
However, the SD characteristics can be 
influenced by several factors such as preparation 
method, carrier type and drug:carrier ratio and 
pH modifiers [7, 8].  
 
Praziquantel (PZQ) is the first drug of choice in 
human taeniasis and schistosomiasis treatment. 
It is classified in Group II of Biopharmaceutical 
Classification System (BCS) and represents an 
example of a drug that requires research to 
improve drug solubility and reduce the high 
doses used in parasitic disease treatment. 
Funding of mass chemotherapy programs aimed 
at reducing the high morbidity rates associated to 
schistosomiasis is required [9].  SSG is the 
sodium salt of a carboxymethyl ether of starch, 
whose molecular weight is typically 500,000 - 
11,000,000, and is widely used in oral 
pharmaceuticals as a disintegrant in capsule and 
tablet formulations. Sodium starch glycolate 
(SSG) is a very fine, white or off white, free 
flowing powder; odorless or almost odorless, 
practically insoluble in water and similarly 
insoluble in most organic solvents. Solid 
dispersion of carbamazepine with SSG increased 
solubility of carbamazepine due to the properties 
of wetting, significant increase in surface area 
and control over the particle size of the drug. 
Solid dispersions of SSG with ibersartan, 
olanzapine itraconazol, carbamazepina, nalidixic 
acid, furosemide [2,10] produced higher 
dissolution rates than with other excipients due 
probably to their rapid dispersibility in the 
aqueous dissolution fluids [11-13]. The objective 
of this study was to investigate the dissolution 
rate of PZQ from solid dispersions (SD) prepared 
with SSG and also to structurally characterize the 
SD by x-ray diffraction (XRD), Fourier 
transformed infrared spectroscopy (FTIR) and 
scanning electron microscopy (SEM). The 
mucoadhesive performance of SD was also 






Praziquantel (PZQ) with a purity of 99.6% was 
purchased from Indukern do Brasil Quimica Ltda 
(Brazil). Sodium starch glycolate was purchased 
from Blanver, Brazil. Other reagents used were 
of analytical grade. 
 
Preparation of solid dispersion 
 
PZQ and SSG were used at SD ratios of 2:1, 1:1, 
1:2 and 1:3. A sufficient amount of ethanol was 
used to dissolve PZQ while SSG was dispersed 
in water. The mixture of PZQ solution with SSG 
dispersion was produced by mechanical agitation 
for 5 min. When a clear solution was obtained, 
the sample was evaporated under reduced 
pressure at 65 ºC (Tecnal® TE-210 rotary 
evaporator) and dried in a freeze-dryer (Edwards 
Modulyo® Freeze-Dryer). The co-precipitate 
(solid dispersion) was crushed in a porcelain 
mortar with a pestle and stored in a silica 
desiccator pending use. The viscosity of the SSG 
dispersion was measured (DV-E Brookfield 
viscometer) before mixing with the PZQ solution. 
 
Preparation of physical mixtures (PM) of PZQ 
and SSG 
 
PZQ and SSG powder mixtures (PM) at ratios of 
2:1, 1:1, 1:2 and 1:3 were prepared by first sifting 
the individual powders through a 425 µm 
aperture screen and mixing together by trituration 
in a mortar with a pestle. The mixture was stored 




The solubility of PZQ was determined in purified 
water. Briefly, 15 ml of water was added to SD or 
PM (containing an equivalent of 15 mg of PZQ) 
in a test tube. The tube was sonicated 40KHZ for 
30 min (Unique – Mod 2800A) and then shaken 
in a water bath (25 °C) for 48 h. A portion of the 
solution (10 ml) was withdrawn, centrifuged at 
2,200 g for 20 min, filtered (0.45µm pore size) 
and centrifuged again at 7,000 g for 10 min 
twice. The upper portion (1 ml) was then taken, 
diluted with 9 ml of ethanol and the diluted 
solution subsequently and analyzed spectro-
photometrically for PZQ content at 263 nm.  
 
In vitro release studies 
 
The release rate of pure PZQ, PZQ in SD and in 
PM was determined using a dissolution test 
(method II, USP 32). The dissolution test was 
performed in 900mL of 0.1M HCl with 0.2 %w/v 
of sodium lauryl sulphate, at 37 ± 0.5 oC, rotating 
at 50 rpm, for 120 min. PZQ sample of 
0.5mg.mL-1 were taken for dissolution studies at 
regular intervals. Withdrawing samples were 
filtered through a membrane filter (Allcrom, 0.22 
µm pore size). The withdrawn sample, in each 
case, was replaced with an equivalent volume of 
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fresh dissolution medium at 37 oC. Absorbance 
of the samples was measured spectrophotome-
trically at 263nm.  
 
Scanning electron microscopy  
 
The external morphology of SD, PM and PZQ 
was studied by scanning electron microscopy 
(SEM). The samples were prepared for SEM by 
lightly sprinkling the powder onto a double-sided 
adhesive tape affixed to an aluminum stub. The 
stubs were then coated with gold to a thickness 
of about 300 Å under an argon atmosphere using 
a gold sputter module in a high-vacuum 
evaporator. The samples were then randomly 
scanned and photomicrographs taken with a 
scanning electron microscope (JSM-6360). 
 
X-ray diffraction analysis 
 
Diffraction patterns (PXRD) of all the samples 
were obtained using X-ray diffraction on a D 
5000- Siemens device (filtered Ni, Cu.Kα 
radiation). The samples were scanned at 
increments of 0.02o from 5º to 40º at a diffraction 
angle of 2. The voltage and currents used were 
40 kV and 50 mA. 
 
Fourier transform infrared spectroscopy  
 
The infrared spectra of pure PZQ and SD, PM 
were obtained by the KBr disk method recorded 
on a Fourier transform infrared (FTIR) 
spectrophotometer (Perkin Elmer, Spectrum 
One). The spectra were obtained by scanning at 
b 400 to 4,000 cm-1 at a resolution of 2cm-1. KBr 
pellets were prepared by gently mixing 1 mg of 




The mechanical properties of SD (1:3) and SSG 
were examined using texture profile analysis 
(TA.XT plus, Stable Micro Systems, UK) [14]. In 
the test, compressed mucin disc was affixed to a 
metal platform using double-sided adhesive tape 
and then affixed onto a cylindrical probe with 
double-sided adhesive tape. The mucin disc was 
hydrated with phosphate buffer (pH 7.4) for 60 s. 
The test was performed in compression mode at 
a speed of 0.5 mm.s-1 under a force of 2 mN. To 
come into contact with the mucin disc, the probe 
containing the sample was moved vertically at a 
speed of 2.0 mm.s-1. After 10 min of contact, the 
probe was moved in the opposite direction at the 
same speed. The maximum force required to 
separate the probe from the mucin disk was 
monitored by the in-built software (Texture 
Exponent Lite). The total force required (Wad) 
was calculated from the area of the plot of force 
versus distance. The analysis was performed in 
duplicate. 
 
Statistical analysis  
 
Two-way analysis of variance (ANOVA) and t 
test were employed for statistical analysis of PZQ 
dissolution rate and solubility data. P ≤ 0.05 was 
considered as indicative of statistically significant 
difference. The study was conducted using the 




The SD preparations were relatively simple and 
the SD mass was sufficiently friable to be ground 
easily. 
 
Solubility and in vitro release of PZQ 
 
Figure 1 shows PZQ solubility in purified water. 
Letters a and b compare the solubility of pure 
PZQ with PZQ in PM or SD. Letters c and d 
compare the solubility of PZQ between the PMs 
and respective SDs. Equal letters indicate no 
statistical difference whereas different letters 
show a statistical difference for p  0.05. In case 
of PMs, drug solubility seemed to decreased with 
increase in concentration of PZQ, and none of 
them achieved the solubility of PZQ SDs. No 
statistical difference between the solubility of 
PZQ pure and the PMs was found. Moreover, a 
statistically significant difference was found 
between the solubility of PZQ pure and SDs as 
well as between physical mixtures and the SDs 
corresponding. 
 
























Figure 1: Solubility of pure PZQ, PM and SD in water 
after 48 h of agitation. Letters a and b compare the 
solubility of pure PZQ with the solubility of PZQ in PM 
and SD. Letters c and d compare the solubility of PZQ 
in PM and corresponding SD. Different letters 
represent statistically significant difference at p  0.05. 
Data are expressed as mean ± SD (n = 3).  
 
Figure 2 shows the dissolution profile of pure 
PZQ and of PZQ in SD (1:3) and PM (1:3) 
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formulations. Dissolved PZQ for PM and SD in 
60 min (PZQ, PM 1:3) was 70 and 88 %, 
respectively. After 120 min (SD, 1:3), the figures 
increased to 76 and 96 %, respectively. Over the 
same time period (120 min.), dissolution of pure 
PZQ was only 64 %.  
 














Figure 2: Dissolution profile of pure PZQ (□), 1:3 solid 
dispersion (●) and 1:3 physical mixture (▲). Data are 
expressed as mean ± SD (n = 6)  
 
Structural and molecular and morphological 
characterization of formulations 
 
The XRD diffractograms of SD, PM and the 
individual components are are shown in Fig 3. 
The polymer clearly exhibited an amorphous 
profile while PZQ was crystalline as evidenced 
by intense diffraction peaks). The diffraction 
pattern of PM was simply the superimposition of 
those of the individual components. On the other 
hand, the diffractogram of SD shows a change in 
the crystal structure of PZQ, revealing a 
transition from a crystalline to an amorphous 
state. 





















Figure 3: X-ray diffractohrams of pure PZQ , SSG, 
and 1:3 ratio of PM and SD  
 
The FTIR of pure PZQ, SD and PM are shown in 
Figure 4. For PZQ, the wide band in the region 
3600 - 3400 cm-1 indicate a characteristic 
stretching of the O-H group which, in this case, 
can be attributed to the presence of water 
molecules. In the region 3000 - 2900 cm-1, 
vibration absorption bands of C-H connections 
are seen, reflecting the symmetrical and 
asymmetric axial deformations of CH2 and CH3 
groups. Stretching bands overlaid at 1651 cm-1 
represent two carbonyls (C = O) stretching 
absorption. At 1437 cm-1, CH2 angular stretching 
symmetrical bands appear with a band overlap 
partially observed at 1651 cm-1 for two 
connections stretching among carbons of the 
aromatic ring. Between 1350 and 1000 cm-1, 
axial deformation occurs with band overlapping 
of C-N and C-H symmetrical angular stretching of 
CH2. With regard to SSG spectrum (Figure 4B), a 
broad band in the region spanning 3600 - 2900 
reflects the OH stretching group of this 
compound molecule. At 1600 - 1000 cm-1, 
overlapping bands reflect asymmetric and 
symmetrical stretching of C-O-C group The 
scanning electron photomicrographs (SEM) of 
PZQ, SD and SSG are displayed in Figure 5. 
Pure PZQ particles were crystalline (A) and SSG 
(B) spherical and non-porous, being oval or 
spherical granules, 30 - 100 µm in diameter but 
with some in the size range of 10 - 35 µm 
(diameter). SD (C) show structural change in the 
particles, with SSG particles losing their spherical 
shape and appear to increase volume. SD 
particles also presented filamentous shape and 
PZQ lost its original crystalline form. 
 
Mucoadhesive adhesive properties of solid 
dispersion 
 
SSG dispersed well in cold water and settled in 
the form of a highly hydrated layer; it exhibited a 
viscosity of 4.21 mPa. After mixing SSG 
dispersion with PZQ solution, the viscosity 
decreased to 3.36 mPa. The mucoadhesion of 
SSG and SD (1:3) was 1497 ± 170 and 1058 ± 
109 μJ, respectively. The forces (N) required to 
detach the formulations from mucin disc was 




In this study, the solubility of PZQ in the SDs 
increased  with increase in SSG concentration 
reaching a maximum at PZQ:SSG ratio of 1:3. 
This can be attributed to the swelling of SSG, 
which has a tendency to absorb water and retain 
it, resulting in up to 250 % increase in particle 
diameter when exposed to water [15]. This 
volume increase in their particle diameter could 
serve as an impediment to drug release and 
could explain the decrease in drug solubility 
observed with an increase in their respective 
concentrations [16]. In this study, increase drug 
solubility may be due to significant reduction of  
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Figure 5: Scanning electron photomicrographs (x 1000) of pure PZQ (A); SSG (B) and SD 1:3 (C) 
 
the crystallinity of the drug, as shown by x-ray 
diffraction results.  
 
Increase in dissolution was partly dependent on 
reduction in drug crystallinity and is consistent 
with solubility results. The greater solubility of 
PZQ in PM than that of the pure drug is an 
indication of increased drug wettability promoted 
by SSG. The results show that PZQ dissolution 
in SD was significantly greater than in PM. 
Enhancement of dissolution of PZQ from solid 
dispersion (SD) can be attributed to several 
factors which affect the mechanism of dissolution 
in solid dispersion. These include reduction of 
drug crystallinity, i.e., amorphization, increased 
wettability and dispersibility [4,5,17]. 
 
PZQ is crystalline while SSG is amorphous. 
However,. This result helps explain the higher 
solubility and dissolution rate of PZQ in SD. The 
smaller diffraction peaks of SD compared with 
those of pure PZQ and PZQ in PM can be 
attributed principally to the conversion of PZQ 
from a crystalline to amorphous state.  
IR indicates that bonding, if present, might not 
have been strong as to suppress the spectral 
band of PZQ. In both SD and PM, the 
characteristic stretching of the functional drug 
groups was preserved, indicating the physical 
and chemical integrity of PZQ remained intact. It 
is therefore presumed that formation of solid 
dispersion or physical mixture does not cause 
any physical and/or chemical interaction between 
PZQ and SSG at molecular level. 
 
Mucoadhesion is used to increase the residence 
time of drug at a specific site [20]. Generally, the 
polymer chains need to be mobile to 
interpenetrate the mucus glycoprotein chains and 
contribute to the consolidation of the 
mucoadhesive phenomenon. SSG, chemically 
described as the sodium salt of a carboxymethyl 
ether of starch, presents, in addition to hydroxyl 
group, only one cluster for ionization and 
interaction with mucin. Although PZQ easily 
permeates the intestinal mucosa, its 
bioavailability is limited by the rate of dissolution. 
However, mucoadhesion associated with 
A B C 
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increased solubility of PZQ in solid dispersion is 
a strategy that can result in improved 




This study shows that the dissolution rate of PZQ 
can be enhanced greatly by the solid dispersion 
technique. The mucoadhesive ability of the SSG 
was confirmed for the SD 1:3 formulation. The 
results of this study, like those of a few others 
exploring solid dispersion strategy, indicate that 
solid dispersion is a viable solution for 
pharmaceutical companies to enhance the life 
cycle of the existing products in which poor 
solubility is a major concern. The SD of PZQ with 
mucoadhesive and hydrodispersible carriers also 
represents a useful strategy for increasing the 
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